Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection.


Journal

Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688

Informations de publication

Date de publication:
05 Jan 2020
Historique:
pubmed: 16 1 2019
medline: 1 7 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

Distributions of serum pepsinogen (PG) values were assessed in Helicobacter pylori-infected and non-infected junior high school students (aged 12-15 years) in Japan. All junior high school students (1,225 in total) in Sasayama city, who were basically healthy, were asked to provide urine and serum samples, which were used to measure urine and serum H. pylori antibodies using ELISA kits and PG values. The subjects, whose urine and serum antibodies were both positive, were considered H. pylori infected. Of the 187 subjects who provided urine and blood samples, 8 were infected, 4 had discrepant results, 4 had negative serum antibody titers no less than 3.0 U/ml, and 171 were non-infected. In the H. pylori non-infected subjects, the median PG I and PG II values and PG I to PG II ratio (PG I/II) were 40.8 ng/mL, 9.5 ng/mL, and 4.4, respectively, whereas in the infected subjects, these values were 55.4 ng/mL, 17.0 ng/mL, and 3.3, respectively (each P < 0.01). In the non-infected subjects, PG I and PG II were significantly higher in males than in females (P < 0.01). The PG I and PG II values were higher, and the PG I/II was lower in H. pylori infected students than in non-infected students. In H. pylori non-infected students, males showed higher PG I and PG II values than females. The distributions of PG values in junior high school students differed from those in adults.

Sections du résumé

BACKGROUND BACKGROUND
Distributions of serum pepsinogen (PG) values were assessed in Helicobacter pylori-infected and non-infected junior high school students (aged 12-15 years) in Japan.
METHODS METHODS
All junior high school students (1,225 in total) in Sasayama city, who were basically healthy, were asked to provide urine and serum samples, which were used to measure urine and serum H. pylori antibodies using ELISA kits and PG values. The subjects, whose urine and serum antibodies were both positive, were considered H. pylori infected.
RESULTS RESULTS
Of the 187 subjects who provided urine and blood samples, 8 were infected, 4 had discrepant results, 4 had negative serum antibody titers no less than 3.0 U/ml, and 171 were non-infected. In the H. pylori non-infected subjects, the median PG I and PG II values and PG I to PG II ratio (PG I/II) were 40.8 ng/mL, 9.5 ng/mL, and 4.4, respectively, whereas in the infected subjects, these values were 55.4 ng/mL, 17.0 ng/mL, and 3.3, respectively (each P < 0.01). In the non-infected subjects, PG I and PG II were significantly higher in males than in females (P < 0.01).
CONCLUSIONS CONCLUSIONS
The PG I and PG II values were higher, and the PG I/II was lower in H. pylori infected students than in non-infected students. In H. pylori non-infected students, males showed higher PG I and PG II values than females. The distributions of PG values in junior high school students differed from those in adults.

Identifiants

pubmed: 30643100
doi: 10.2188/jea.JE20180119
pmc: PMC6908843
doi:

Substances chimiques

Antibodies, Bacterial 0
Pepsinogen C 61536-72-9
Pepsinogen A 9001-10-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

30-36

Références

J Gastroenterol Hepatol. 2015 Oct;30(10):1473-7
pubmed: 25974661
Int J Biol Markers. 2010 Oct-Dec;25(4):207-12
pubmed: 21161942
Am J Gastroenterol. 1997 Jan;92(1):84-8
pubmed: 8995943
Gastroenterol Jpn. 1987 Apr;22(2):133-41
pubmed: 3596151
Pediatr Int. 2013 Jun;55(3):337-41
pubmed: 23360308
J Infect Dis. 1998 Aug;178(2):460-5
pubmed: 9697727
Am J Gastroenterol. 1994 Aug;89(8):1211-8
pubmed: 8053437
J Int Med Res. 2003 Jul-Aug;31(4):247-52
pubmed: 12964499
Helicobacter. 2015 Apr;20(2):133-8
pubmed: 25382113
J Epidemiol. 2014;24(1):47-51
pubmed: 24240631
Cancer. 1994 Jun 1;73(11):2695-702
pubmed: 8194008
Jpn J Cancer Res. 2000 Aug;91(8):774-9
pubmed: 10965016
J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):568-9
pubmed: 15572903
Diagn Microbiol Infect Dis. 2007 Jan;57(1):35-8
pubmed: 16949782
Jpn J Cancer Res. 2000 May;91(5):471-6
pubmed: 10835490
Dig Dis. 2007;25(3):206-13
pubmed: 17827941
Helicobacter. 2017 Apr;22(2):
pubmed: 27785853
Clin Chim Acta. 2009 Apr;402(1-2):54-60
pubmed: 19135434
J Clin Microbiol. 1999 Oct;37(10):3328-31
pubmed: 10488200
J Med Screen. 2004;11(3):141-7
pubmed: 15333273
J Gastroenterol. 2011 Dec;46(12):1353-60
pubmed: 21853260
Helicobacter. 2017 Feb;22(1):
pubmed: 27400382
Cancer. 1995 Jun 15;75(12):2789-93
pubmed: 7773928
Gastroenterology. 1971 Aug;61(2):185-8
pubmed: 4935210
J Epidemiol. 2019 Apr 5;29(4):147-154
pubmed: 30249942
PLoS One. 2014 Jan 15;9(1):e83999
pubmed: 24454714
Am J Hum Genet. 1982 May;34(3):395-401
pubmed: 7081219
Scand J Gastroenterol. 2006 May;41(5):524-31
pubmed: 16638693
Jpn J Cancer Res. 1993 Oct;84(10):1086-90
pubmed: 8226283

Auteurs

Masumi Okuda (M)

Department of Pediatrics, Aichi Medical University School of Medicine.
Department of General Medicine and Community Health Science, Hyogo College of Medicine.

Yingsong Lin (Y)

Department of Public Health, Aichi Medical University, School of Medicine.

Katsuhiro Mabe (K)

Department of Cancer Preventive Medicine, Graduate School of Medicine, Hokkaido University.

Mototsugu Kato (M)

Division of Endoscopy, Hokkaido University Hospital.

Takako Osaki (T)

Department of Infectious Diseases, Kyorin University School of Medicine.

Ryosuke Miyamoto (R)

Department of Pediatrics, Aichi Medical University School of Medicine.

Akihisa Okumura (A)

Department of Pediatrics, Aichi Medical University School of Medicine.

Shigeru Kamiya (S)

Department of Infectious Diseases, Kyorin University School of Medicine.

Shogo Kikuchi (S)

Department of Public Health, Aichi Medical University, School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH